ciprofloxacin has been researched along with Agnogenic Myeloid Metaplasia in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zlitni, S | 1 |
| Bishara, A | 1 |
| Moss, EL | 1 |
| Tkachenko, E | 1 |
| Kang, JB | 1 |
| Culver, RN | 1 |
| Andermann, TM | 1 |
| Weng, Z | 1 |
| Wood, C | 1 |
| Handy, C | 1 |
| Ji, HP | 1 |
| Batzoglou, S | 1 |
| Bhatt, AS | 1 |
1 other study available for ciprofloxacin and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Strain-resolved microbiome sequencing reveals mobile elements that drive bacterial competition on a clinical timescale.
Topics: Anti-Infective Agents; Azacitidine; Azithromycin; Bacteria; Ciprofloxacin; Diet; DNA, Bacterial; Fec | 2020 |